ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 25 filers reported holding ENZYMOTEC LTD in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $207,000 | -87.0% | 17,913 | -90.9% | 0.00% | -85.7% |
Q2 2017 | $1,592,000 | -23.8% | 196,306 | -17.2% | 0.01% | -30.0% |
Q1 2017 | $2,088,000 | +38.6% | 237,184 | +3.2% | 0.01% | +42.9% |
Q4 2016 | $1,506,000 | -5.5% | 229,862 | +0.7% | 0.01% | -12.5% |
Q3 2016 | $1,594,000 | -23.2% | 228,304 | -8.1% | 0.01% | -27.3% |
Q2 2016 | $2,076,000 | +36.3% | 248,317 | +47.2% | 0.01% | +37.5% |
Q1 2016 | $1,523,000 | +31.6% | 168,738 | +42.9% | 0.01% | +33.3% |
Q4 2015 | $1,157,000 | +149.4% | 118,072 | +129.8% | 0.01% | +100.0% |
Q3 2015 | $464,000 | +714.0% | 51,370 | +647.4% | 0.00% | – |
Q2 2015 | $57,000 | +16.3% | 6,873 | 0.0% | 0.00% | – |
Q1 2015 | $49,000 | -7.5% | 6,873 | 0.0% | 0.00% | – |
Q4 2014 | $53,000 | +15.2% | 6,873 | 0.0% | 0.00% | – |
Q3 2014 | $46,000 | -77.0% | 6,873 | -53.3% | 0.00% | -100.0% |
Q2 2014 | $200,000 | -86.1% | 14,713 | -77.6% | 0.00% | -87.5% |
Q1 2014 | $1,442,000 | +111.4% | 65,575 | +159.5% | 0.01% | +100.0% |
Q4 2013 | $682,000 | – | 25,272 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TIGER MANAGEMENT L.L.C. | 804,854 | $7,284,000 | 0.97% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 96,600 | $874,000 | 0.33% |
Visium Asset Management, LP | 2,200,000 | $19,910,000 | 0.27% |
Paulson & Co. | 4,238,275 | $38,356,000 | 0.20% |
Rotella Capital Management, Inc. | 17,118 | $155,000 | 0.05% |
MENTA CAPITAL LLC | 15,870 | $144,000 | 0.02% |
Renaissance Technologies | 146,000 | $1,321,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 147,144 | $1,332,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 51,370 | $464,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 947,723 | $8,577,000 | 0.00% |